The design and analysis of half life and recovery studies for factor viii and factor ix
Morfini, M.; Lee, M.; Messori, A.
Thrombosis and Haemostasis 66(3): 384-386
1991
ISSN/ISBN: 0340-6245 Accession: 033751980
Full-Text Article emailed within 1 workday
Payments are secure & encrypted
References
Morfini, M.; Lee, M.; Messori, A. 1991: The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis Thrombosis and Haemostasis 66(3): 384-386Sultan, Y.; White, G.C.; Aronstam, A.; Bosser, C.; Brackmann, H.H.; Brochier, G.; Gormsen, J.; Mariani, G.; Roberts, H.R.; Scarabin, Y. 1986: Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII Nouvelle Revue Francaise D'hematologie 28(2): 85-89
Friedman, K.D.; Ottum, M.D.; Endres, J.L.; Montgomery, R.R.; Gill, J.C. 2002: Unexpected Break-Through Bleeds in Hemophilic Children on Treatment with B-Domain-Deleted Factor VIII Concentrate Studies of Factor VIII C Recovery and Half-Life in 3 Symptomatic Children Blood 100(11): Abstract No. 480
Hellstern, P.; Miyashita, C.; Koehler, M.; Kiehl, R.; Schwerdt, H.; Von Blohn, C.; Buettner, M.; Wenzel, E. 1986: Recovery and half life of factor viii coagulant activity and coagulant antigen after administration of heat treated steam treated and cold sterilized high purity factor viii concentrates in hemophilia a patients comparison of five factor viii assays Ricerca in Clinica e in Laboratorio 16(1): 219
Schimpf, K.; Reis, B. 1986: Comparison of recovery and half life of a new factor viii high purity concentrate with a factor viii hs hemate p Ricerca in Clinica e in Laboratorio 16(1): 231
Takase, T. 1978: Studies on factor viii during coagulation process part 1 levels of factor viii pro coagulant factor viii related antigen and von willebrand factor in plasma and serum of normal children patients with hemophilia a or von willebrands disease Journal of the Nagoya Medical Association 29(1): 61-68
Miyashita, C.; Hellstern, P.; Rodemer, B.; Kiehl, R.; Wenzel, E. 1986: Recovery and half life of human factor viii concentrates in the hemophiliac dog and the interaction of f viii c and f viii ag Haemostasis 16(Suppl 5): 26
Ito, M.; Kobayashi, I.; Shinada, S.; Tsukada, T.; Matsuoka, M. 1972: Immunologic studies of factor viii part 2 factor viii and anti factor viii neutralizing capacity in various diseases Acta Haematologica Japonica 35(3): 422
Takase, T. 1978: Studies on factor viii during coagulation process part 2 factor viii pro coagulant activity factor viii related antigen and von willebrand factor during coagulation process accelerated by several kinds of thromboplastic substance Journal of the Nagoya Medical Association 29(1): 69-81
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Ballard, J.O.; Sanders, J.C.; Eyster, M.E. 1981: Altered serum factor VIII-related antigen (VIIi : AGN)/von Willebrand factor (VIIi : vWf) in haemophiliacs with inhibitors to factor VIIi procoagulant activity (VIIi : C) Thrombosis and Haemostasis 45(1): 68-72
Sudheesh, K.M.; Bharani, K.S.N.Siva.; Kiran, H.Y.; Hanagavadi, S. 2016: "Antihemophilic factor is not the only answer for all factor VIII deficiencies." Case report of odontogenic infection in a patient with hemophilia A, complicated by factor VIII inhibitors, and managed by transfusion of antihemophilic factor and factor VIII inhibitor bypass activity Indian Journal of Dentistry 7(3): 149-152
Hellstern, P.; Kiehl, R.; Miyashita, C.; Schwerdt, H.; von Blohn, G.; Köhler, M.; Büttner, M.; Wenzel, E. 1986: Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay Thrombosis and Haemostasis 56(3): 353-359
Foster, P.A.; Fulcher, C.A.; Houghten, R.A.; de Graaf Mahoney, S.; Zimmerman, T.S. 1988: Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain Journal of Clinical Investigation 82(1): 123-128
Dettori, A.G.; Pini, M.; Megha, A.; Portioli, D.; Ponari, O. 1981: The hemostatic system in peripheral arterial disease 2. variations in factor viii components factor viii coagulant activity factor viii related antigen von willebrand factor before and after venous occlusion Thrombosis Research 22(5-6): 559-564